LUBRITEQ
LIVE

Serial Number

99465629

Owner

Carl Freudenberg KG

Attorney

Jessica S. Sachs

Filing Date

Oct 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LUBRITEQ Trademark

Serial Number: 99465629

LUBRITEQ is a trademark filed by Carl Freudenberg KG on October 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Carl Freudenberg KG (7 trademarks)

Hoehnerweg 2-4
Weinheim 69469 , DE

Entity Type: 30

Trademark Details

Filing Date

October 28, 2025

Registration Date

Not Registered

Goods & Services

Scientific and technological services, namely, scientific research, analysis, and testing in the field of hydrophilic coatings and research and design relating thereto; Industrial research in the field of hydrophilic coatings and design relating thereto; Industrial analysis of hydrophilic coatings, industrial research in the field of hydrophilic coatings and industrial design services; quality control for others; providing biochemical, pharmaceutical and medicine-technological research services; Product and scientific research and development in the field of coatings relating to medical devices; Commissioned product and scientific research, commissioned product development work and related consultancy in the field of coating surfaces for medical devices

Surgical implants comprising of living tissue with hydrophilic coating

Hydrophilic coating sold as an integral component of surgical, medical, dental and veterinary apparatus and instruments, namely, catheters, medical guidewires, hydrophilic guidewires to track catheters, medical endoscopes, stent delivery systems, synthetic stent grafts, artificial vascular grafts, and vascular sheaths; Surgical, medical, dental and veterinary apparatus and instruments, namely, surgical implants comprised of artificial materials with hydrophilic coating, drug-device products in the nature of syringes and infusion sets with hydrophilic coatings, catheters, medical guidewires, medical introducers and introducer sheaths, catheter tubes, synthetic stent grafts and stent delivery systems, endoscopic and minimally invasive surgical instruments, surgical instruments, implant drug delivery port systems, drug delivery devices in the nature of implantable drug delivery pumps, wound care products in the nature of medical devices for closing wounds, medical diagnostic devices and microfluidic devices for medical purposes with hydrophilic coating, artificial heart parts, artificial heart valves, articles for medical use for the contact with blood in the nature of collecting tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation except vascular filtration devices; surgical implants comprising of artificial materials, anti-thrombotic and anti-coagulative surgical implants comprising of artificial materials, surgical implants comprising of artificial materials coated with heparin, heparin derivatives or macromolecular agents, articles for medical use and for the contact with blood in the nature of apparatus for blood analysis, apparatus for taking blood, blood collection needles, and blood testing apparatus coated with heparin, heparin derivatives or macromolecular agents in the nature of tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation, vascular filtration devices; artificial limbs, eyes and teeth; massage apparatus for medical use; medical devices, namely, artificial and natural surfaces in the nature of blood-contacting medical device surfaces, vascular and endovascular device surfaces, implantable medical device surfaces, drug-delivery system surfaces, surgical and endoscopic instrument surfaces, diagnostic and microfluidic device surfaces, wound-management device surfaces, and surgical implants comprised of artificial tissue with hydrophilic coating, drug-device products in the nature of implantable drug delivery pumps with hydrophilic coatings, catheters, medical guidewires, medical introducers and introducer sheaths, catheter tubes, synthetic stent grafts and stent delivery systems, endoscopic and minimally invasive surgical instruments, surgical instruments, implant drug delivery port systems, drug delivery devices in the nature of implantable drug delivery pumps, wound care products in the nature of medical devices for closing wounds, medical diagnostic devices and microfluidic devices for medical purposes with hydrophilic coating, artificial heart parts, artificial heart valves, articles for medical use for the contact with blood in the nature of collecting tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation except vascular filtration devices

Chemicals for use in industry and science and chemical preparations for use in photography; unprocessed plastics; biological preparations for use in industry and science; polymer resins in their raw state; polymeric substances with hydrophilic properties for use in manufacturing coatings medical devices; chemical coatings in the nature of hydrophilic coatings for use in the manufacture of medical devices and pharmaceutical preparations; chemical compositions in the nature of hydrophilic coatings for use in the manufacture of polymer coatings for medical devices

Treatment of materials, namely, treatment of metals, polymers, elastomers, glass, ceramics, composites; commissioned application of coatings via a wet chemical process to medical devices surfaces; application of hydrophilic coatings via a wet chemical process to medical devices

Hydrophilic coatings for medical devices and veterinary devices; coatings for medical devices, for delivery of a wide range of pharmaceuticals, sold separately from the medical devices; Hydrophilic coatings for medical devices; hydrophilic coatings for medical devices; hydrophilic surface coatings for medical devices; hydrophilic polymer coatings for medical devices

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 10, 2026 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Sep 2, 2026 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Sep 2, 2026 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Sep 2, 2026 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 31, 2026 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jun 16, 2026 GNS1
SUBSEQUENT FINAL EMAILED
Jun 16, 2026 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jun 16, 2026 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 16, 2026 GNFN
FINAL REFUSAL E-MAILED
Jun 16, 2026 GNFR
FINAL REFUSAL WRITTEN
Jun 16, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 9, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 28, 2025 MAFR
NEW APPLICATION ENTERED
Oct 28, 2025 NWAP